CDXS - Codexis to Participate at Three Investment Conferences in May
REDWOOD CITY, Calif., May 14, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that management will participate in three upcoming investment conferences:
- UBS Global Healthcare Conference on May 21 at 8:00 a.m. Eastern time at the Grand Hyatt in New York City;
- 16th Annual Craig-Hallum Institutional Conference on Wednesday, May 29 at the Renaissance Minneapolis Hotel, The Depot;
- KeyBanc Capital Markets’ Industrials and Basic Materials Conference on Thursday, May 30 at the Intercontinental Boston.
A live webcast and replay of the presentation at the UBS Global Healthcare Conference will be available on the Investors section of the company’s website, http://ir.codexis.com/.
About Codexis, Inc.
Codexis is a leading protein engineering company that applies its proprietary CodeEvolver® technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. Codexis’ proven technology enables improvements in protein performance, meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial-scale implementations of biocatalytic processes. For more information, see www.codexis.com
Contacts:
Investors
LHA Investor Relations
Jody Cain, 310-691-7100
jcain@lhai.com